Clinical Trial Update: Using Ultrasound Spectrum Analysis (USA) to Guide Dose Escalated Prostate Brachytherapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating ultrasound spectrum analysis to guide dose-escalated prostate brachytherapy planning in prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Beth Israel Medical Center | Conditions: Clinical Stage T2b or Less of Prostate Cancer, Prostate Brachytherapy | Phase 1, Phase 2 | Status: COMPLETED